Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Bases de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Pathol ; 242(2): 234-245, 2017 06.
Artigo em Inglês | MEDLINE | ID: mdl-28191908

RESUMO

Atopic dermatitis (AD) is a common skin inflammatory disease characterized by the production of thymic stromal lymphopoietin (TSLP) and marked TH 2 polarization. Recent studies suggest that IL-1ß contributes to the development of AD skin inflammation. Here, we have investigated the impact of IL-1ß signalling on the epidermal homeostasis of both healthy subjects and AD patients [with functional filaggrin (FLG) alleles], with particular attention to TSLP production and keratinocyte differentiation. In healthy reconstructed human epidermis (RHE), IL-1ß promoted (i) robust secretion of TSLP in an NF-κB-dependent manner and (ii) a significant decrease in the expression of filaggrin and other proteins of the epidermal differentiation complex. These effects were prevented by treatment of RHE with the anti-IL-1ß mAb canakinumab and by the IL-1 receptor antagonist anakinra. Interestingly, RHE generated from AD donors behaved like that of healthy individuals and showed comparable responses to IL-1ß signals. Collectively, our results suggest that IL-1ß may be an early key mediator for the acquisition of an AD phenotype through induction of TSLP and alteration of the epidermal homeostasis. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.


Assuntos
Citocinas/genética , Dermatite Atópica/genética , Interleucina-1beta/genética , Adulto , Anticorpos Monoclonais/uso terapêutico , Anticorpos Monoclonais Humanizados , Diferenciação Celular , Citocinas/metabolismo , Dermatite Atópica/tratamento farmacológico , Dermatite Atópica/metabolismo , Dermatite Atópica/patologia , Epiderme/metabolismo , Epiderme/patologia , Feminino , Proteínas Filagrinas , Homeostase , Humanos , Proteína Antagonista do Receptor de Interleucina 1/uso terapêutico , Interleucina-1beta/metabolismo , Proteínas de Filamentos Intermediários/genética , Proteínas de Filamentos Intermediários/metabolismo , Masculino , Pessoa de Meia-Idade , NF-kappa B/genética , NF-kappa B/metabolismo , Fenótipo , Adulto Jovem , Linfopoietina do Estroma do Timo
2.
Waste Manag ; 150: 267-279, 2022 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-35870362

RESUMO

In Material Recovery Facilities (MRFs), recyclable municipal solid waste is turned into a precious commodity. However, effective recycling relies on effective waste sorting, which is still a challenge to sustainable development of our society. To help the operations improve and optimise their process, this paper describes PortiK, a solution for automatic waste analysis. Based on image analysis and object recognition, it allows for continuous, real-time, non-intrusive measurements of mass composition of waste streams. The end-to-end solution is detailed with all the steps necessary for the system to operate, from hardware specifications and data collection to supervisory information obtained by deep learning and statistical analysis. The overall system was tested and validated in an operational environment in a material recovery facility. PortiK monitored an aluminium can stream to estimate its purity. Aluminium cans were detected with 91.2% precision and 90.3% recall, respectively, resulting in an underestimation of the number of cans by less than 1%. Regarding contaminants (i.e. other types of waste), precision and recall were 80.2% and 78.4%, respectively, giving an 2.2% underestimation. Based on five sample analyses where pieces of waste were counted and weighed per batch, the detection results were used to estimate purity and its confidence level. The estimation error was calculated to be within ±7% after 5 minutes of monitoring and ±5% after 8 hours. These results have demonstrated the feasibility and the relevance of the proposed solution for online quality control of aluminium can stream.


Assuntos
Eliminação de Resíduos , Gerenciamento de Resíduos , Alumínio , Computadores , Reciclagem/métodos , Eliminação de Resíduos/métodos , Resíduos Sólidos/análise , Gerenciamento de Resíduos/métodos
3.
Front Oncol ; 10: 1506, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32974182

RESUMO

The tissue stroma plays a major role in tumors' natural history. Most programs for tumor progression are not activated as cell-autonomous processes but under the conditions of cross-talks between tumor and stroma. Adipose tissue is a major component of breast stroma. This study compares adipose tissues in tumor-bearing breasts to those in tumor-free breasts with the intention of defining a signature that could translate into markers of cancer risk. In tumor-bearing breasts, we sampled adipose tissues adjacent to, or distant from the tumor. Parameters studied included: adipocytes size and density, immune cell infiltration, vascularization, secretome and gene expression. Adipose tissues from tumor-bearing breasts, whether adjacent to or distant from the tumor, do not differ from each other by any of these parameters. By contrast, adipose tissues from tumor-bearing breasts have the capacity to secrete twice as much interleukin 8 (IL-8) than those from tumor-free breasts and differentially express a set of 137 genes of which a significant fraction belongs to inflammation, integrin and wnt signaling pathways. These observations show that adipose tissues from tumor-bearing breasts have a distinct physiological status from those from tumor-free breasts. We propose that this constitutive status contributes as a non-cell autonomous process to determine permissiveness for tumor growth.

4.
ESMO Open ; 3(1): e000257, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29344407

RESUMO

BACKGROUND: Antiprogrammed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) therapies have demonstrated promising activity in advanced head and neck squamous cell carcinoma (HNSCC), with overall response rates of approximately 20% in unselected populations and survival benefit. Whether induction docetaxel, platinum and fluorouracil (TPF) modifies PD-L1 expression or tumour immune infiltrates is unknown. PATIENTS AND METHODS: Patients with locally advanced HNSCC treated at Gustave Roussy (Villejuif, France) between 2006 and 2013 by induction TPF followed by surgery were retrospectively considered. Patients with paired samples (pre-TPF and post-TPF) were kept for further analysis. PD-L1 expression was quantified by immunohistochemistry according to a validated protocol. The objective of the study was to compare PD-L1 expression on tumour cells (TC) and immune cells (IC) (positivity threshold of ≥5%) before and after TPF. CD8+ and Foxp3+ lymphocytes densities before and after TPF were also quantified. RESULTS: Out of 313 patients receiving induction TPF, 86 underwent surgery; paired samples were available for 21 of them. Baseline PD-L1 expression was ≥5% in two and five samples for TC and IC, respectively. A significant increase of PD-L1 expression was observed after TPF, with 15 samples (71%) presenting a positive staining in IC after induction chemotherapy (P=0.003; Wilcoxon rank-sum test) and eight samples (38%) in TC (P=0.005; Wilcoxon rank-sum test). Tumour-infiltrating CD8+ mean densities also significantly increased post-TPF (P=0.01). There was no significant difference in Foxp3+ expression, CD8/Foxp3 ratio or correlation with outcome. CONCLUSION: TPF induction chemotherapy in advanced HNSCC increases PD-L1 positivity on tumour-infiltrating ICs, as well as CD8+ lymphocytes density. These results warrant independent validation on larger datasets and might help therapeutic strategy in advanced HNSCC.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA